Steps in this run
| Step |
Calls |
Tokens in |
Cache hit |
Cost |
|
ranking
|
2 |
77,605 |
|
$0.69810 |
|
haiku prescreen
|
4 |
38,993 |
|
$0.03535 |
All 6 API calls — tap to expand
$0.014687
Est. cost (USD)
Result preview
```json
[
{
"post_index": 56,
"cluster_ids": [9, 1],
"claim": "FDA Galleri blood test premarket approval signals AI early detection market structure",
"argument_type": "empirical_claim",
"stance": "neutral_analysis",
"hyde_excerpt": "The FDA's advisory committee review of GRAIL's Galleri multi-cancer early detection test represents a critical regulatory checkpoint for AI-
$0.011641
Est. cost (USD)
Result preview
```json
[
{
"post_index": 40,
"cluster_ids": [1, 12],
"claim": "COVID-19 leaves measurable structural brain damage visible on neuroimaging",
"argument_type": "empirical_claim",
"stance": "neutral_analysis",
"hyde_excerpt": "Recent neuroimaging studies document structural and functional changes in brain regions associated with memory, attention, and emotion processing foll
$0.002190
Est. cost (USD)
Result preview
```json
[]
```
35,409
Tokens in (billed)
$0.370970
Est. cost (USD)
Result preview
```json
[
{
"post_index": 4,
"matched_article_id": 646,
"match_confidence": 82,
"match_reason": "The FDA post announces a webinar on draft guidance for leveraging prior knowledge in genome editing therapy development, and article ID:646 analyzes exactly this FDA June 2026 draft guidance — arguing that sponsors can reuse CMC, nonclinical, bioinformatics, and clinical data across g
$0.006827
Est. cost (USD)
Result preview
```json
[
{
"post_index": 15,
"cluster_ids": [17, 8],
"claim": "Low-cost MRI manufacturing reduces diagnostic imaging access barriers in price-sensitive markets",
"argument_type": "empirical_claim",
"stance": "challenges_status_quo",
"hyde_excerpt": "Diagnostic imaging costs represent a structural barrier to early detection and preventive care in price-constrained healthc
38,258
Tokens in (billed)
$0.327125
Est. cost (USD)
Result preview
```json
[]
```